Theravance Biopharma Aktie
13,90
EUR
-0,20
EUR
-1,42
%
16,23
USD
-0,17
USD
-1,04
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung